ストックスクリーナーアプリを入手
24.28
1.36%
0.2986
前日終値:
$23.98
開ける：
$23.99
24時間の取引高:
2.71M
Relative Volume:
0.47
時価総額：
$12.14B
収益：
$4.72B
当期純損益:
$-232.00M
株価収益率:
-52.07
EPS:
-0.4663
ネットキャッシュフロー:
$284.00M
1週間 パフォーマンス:
+11.85%
1か月 パフォーマンス:
+11.49%
6か月 パフォーマンス:
+4.45%
1年 パフォーマンス:
+79.77%
1日の値動き範囲:
$23.74
$24.41
1週間の範囲:
$21.63
$24.41
52週間の値動き範囲:
$13.09
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
名前
Elanco Animal Health Inc
セクター
電話
877-352-6261
住所
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
24.30 | 11.98B | 4.72B | -232.00M | 284.00M | -0.4663 |
TAK
Takeda Pharmaceutical Co Adr
|
15.99 | 51.03B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.90 | 40.20B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.135 | 40.78B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
78.31 | 32.81B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
554.92 | 23.86B | 3.17B | 1.29B | 1.01B | 27.09 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-15 | 開始されました | Citigroup | Buy |
| 2026-01-22 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-11-21 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | アップグレード | Argus | Hold → Buy |
| 2025-10-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-07-17 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 開始されました | UBS | Buy |
| 2024-12-02 | 開始されました | Leerink Partners | Market Perform |
| 2024-09-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | アップグレード | Stifel | Hold → Buy |
| 2023-12-19 | 開始されました | Jefferies | Buy |
| 2023-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
| 2023-04-20 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-08-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-07-21 | ダウングレード | Goldman | Buy → Sell |
| 2022-07-12 | 開始されました | Piper Sandler | Neutral |
| 2021-11-18 | 開始されました | Morgan Stanley | Overweight |
| 2021-10-28 | ダウングレード | Stifel | Buy → Hold |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-06-15 | アップグレード | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2021-05-11 | アップグレード | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 開始されました | Stifel | Buy |
| 2021-03-22 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2021-02-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | ダウングレード | Argus | Buy → Hold |
| 2020-11-09 | ダウングレード | Barclays | Overweight → Underweight |
| 2020-08-20 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 再開されました | Credit Suisse | Neutral |
| 2020-08-04 | 再開されました | Goldman | Buy |
| 2020-07-27 | ダウングレード | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-19 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 開始されました | Barclays | Overweight |
| 2019-08-26 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | アップグレード | UBS | Sell → Neutral |
| 2019-05-23 | 開始されました | Guggenheim | Neutral |
| 2019-03-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 再開されました | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 開始されました | William Blair | Mkt Perform |
| 2019-01-23 | 開始されました | UBS | Sell |
| 2019-01-15 | 開始されました | Argus | Buy |
| 2018-10-15 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Elanco Animal Health Inc (ELAN) 最新ニュース
Elanco Animal Health 2026 Shareholder Meeting Results: Board Elections and Executive Compensation Vote - Minichart
A Look at Elanco Animal Health Inc (ELAN) After 3.8% Gain -- GF Value $15.53 vs Price $23.69 - GuruFocus
Elanco (NYSE: ELAN) investors reelect board and ratify 2026 auditor - Stock Titan
Monumental Public-Private Initiative Forms to Permanently Close America’s Protein Gap - CSRwire
A Look at Elanco Animal Health Inc (ELAN) After 5.0% Gain -- GF Value $15.53 vs Price $22.82 - GuruFocus
Board member at Elanco (NYSE: ELAN) granted new equity awards - Stock Titan
Elanco (NYSE: ELAN) director receives deferred and restricted stock units - Stock Titan
Elanco Animal Health (ELAN) director granted new equity awards - Stock Titan
[Form 4] Elanco Animal Health Inc Insider Trading Activity - Stock Titan
Elanco (NYSE: ELAN) director receives 4,678 deferred stock units - Stock Titan
Board member gets 4,678-share equity award at Elanco (NYSE: ELAN) - Stock Titan
Elanco (ELAN) director Harrington granted deferred and restricted stock units - Stock Titan
Elanco (ELAN) director granted stock and deferred unit awards as compensation - Stock Titan
Elanco (NYSE: ELAN) director Stacey Ma receives annual equity grants - Stock Titan
Elanco (NYSE: ELAN) director granted deferred and restricted stock units - Stock Titan
Elanco Animal Health (ELAN) Stock Analysis: Exploring Potential 37% Upside with Strong Buy Ratings - DirectorsTalk Interviews
Q1 2026 Elanco Animal Health Inc Earnings Call Transcript - GuruFocus
Q1 Rundown: Elanco (NYSE:ELAN) Vs Other Pharmaceuticals Stocks - Yahoo Finance
ELAN Stock Price, Quote & Chart | ELANCO ANIMAL HEALTH INC (NYSE:ELAN) - ChartMill
Elanco Animal Health Inc Annual Shareholders Meeting Transcript - GuruFocus
Elanco Launches Befrena As New Dermatology Driver For Undervalued Shares - Yahoo Finance
Companion Animal Health Market is expected to Hit US$ 56.60 - openPR.com
Is Elanco Animal Health Inc (ELAN) Overvalued After 5.3% Rally? - GuruFocus
Is Elanco Animal Health Inc (ELAN) Overvalued After 5.3% Rally? GF Value Says Overvalued - GuruFocus
Elanco CEO Jeffrey Simmons buys $99,842 in company stock By Investing.com - Investing.com South Africa
Elanco EVP Rajeev Modi buys $99,938 of company stock By Investing.com - Investing.com South Africa
Elanco EVP Rajeev Modi buys $99,938 of company stock - Investing.com UK
Elanco CEO Jeffrey Simmons buys $99,842 in company stock - Investing.com UK
Elanco (NYSE: ELAN) officer Modi buys shares and receives deferred stock units - Stock Titan
Elanco (NYSE: ELAN) CEO adds shares and receives deferred units - Stock Titan
Elanco (NYSE: ELAN) CFO receives grant of deferred stock units as compensation - Stock Titan
Elanco Animal Health Launches Canine Dermatitis Drug Befrena - Moomoo
Elanco Animal Health’s SWOT analysis: stock outlook amid growth targets - Investing.com India
Elanco Animal Health’s SWOT analysis: stock outlook amid growth targets By Investing.com - Investing.com Nigeria
Elanco (ELAN) Launches New Canine Allergy Treatment Befrena - GuruFocus
Elanco launches canine dermatitis treatment Befrena in U.S. By Investing.com - Investing.com Canada
New dog allergy shot from Elanco offers 6–8 weeks of itch relief - Stock Titan
Elanco Animal Health (ELAN) Stock Report: A Healthcare Stock with Nearly 50% Upside Potential - DirectorsTalk Interviews
Elanco Q1 2026 Earnings: Revenue $1.37B, EPS $0.40, Guidance RaisedNews and Statistics - IndexBox
5 Insightful Analyst Questions From Elanco’s Q1 Earnings Call - Yahoo Finance
Elanco Animal Health Inc (ELAN) Shares Fall 8.2% -- What GF Scor - GuruFocus
Elanco Animal Health Inc (ELAN) Shares Fall 8.2% -- What GF Score of 70 Tells Investors - GuruFocus
Elanco finalizes acquisition of AHV International - Feed Strategy
Morgan Stanley Maintains Elanco Animal Health(ELAN.US) With Hold Rating, Raises Target Price to $23 - Moomoo
Elanco to Participate in Investor Conferences - Intellectia AI
Elanco to Participate in Upcoming Investor Conferences - GuruFocus
Dodge & Cox holds 13.9% of Elanco (NYSE: ELAN) in 13G/A amendment - Stock Titan
How to listen in as Elanco execs talk to investors in May and June - Stock Titan
Elanco reaches $9.3M settlement with consumers over antitrust allegations involving flea and tick products - Indianapolis Business Journal
Elanco Animal Health Inc (ELAN) 財務データ
収益
当期純利益
現金流量
EPS
0.37%
0.44%
大文字化:
|
ボリューム (24 時間):